Issued Patents All Time
Showing 26–50 of 136 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10472335 | Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet | 2019-11-12 |
| 10358433 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more | 2019-07-23 |
| 10336773 | Neprilysin inhibitors | Roland Gendron | 2019-07-02 |
| 10315984 | Neprilysin inhibitors | Melissa Fleury | 2019-06-11 |
| 10189823 | Neprilysin inhibitors | Melissa Fleury | 2019-01-29 |
| 10172834 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2019-01-08 |
| 10138220 | Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity | Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more | 2018-11-27 |
| 10130642 | Neprilysin inhibitors | Melissa Fleury, Roland Gendron | 2018-11-20 |
| 10123984 | Neprilysin inhibitors | Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran | 2018-11-13 |
| 10100021 | Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone | 2018-10-16 |
| 10053417 | Neprilysin inhibitors | Erik Fenster, Melissa Fleury | 2018-08-21 |
| 10005740 | Neprilysin inhibitors | Melissa Fleury, Anne-Marie Beausoleil, Daniel D. Long, Donna A. A. Wilton | 2018-06-26 |
| 9981999 | Neprilysin inhibitors | Melissa Fleury | 2018-05-29 |
| 9975875 | Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity | Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more | 2018-05-22 |
| 9884807 | Neprilysin inhibitors | Melissa Fleury | 2018-02-06 |
| 9872855 | (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2018-01-23 |
| 9873685 | Neprilysin inhibitors | Melissa Fleury | 2018-01-23 |
| 9873696 | Neprilysin inhibitors | Cameron Smith, Ryan Hudson | 2018-01-23 |
| 9868698 | (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid | Erik Fenster, Melissa Fleury, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more | 2018-01-16 |
| 9845332 | Neprilysin inhibitors | Roland Gendron, Melissa Fleury | 2017-12-19 |
| 9839639 | Neprilysin inhibitors | Melissa Fleury, Anne-Marie Beausoliel, Daniel D. Long, Donna A. A. Wilton | 2017-12-12 |
| 9840460 | Neprilysin inhibitors | Erik Fenster, Melissa Fleury | 2017-12-12 |
| 9828367 | Neprilysin inhibitors | Roland Gendron | 2017-11-28 |
| 9783507 | Neprilysin inhibitors | Melissa Fleury, Anne-Marie Beausoliel, Daniel D. Long, Donna A. A. Wilton | 2017-10-10 |
| 9771337 | Neprilysin inhibitors | Melissa Fleury, Roland Gendron, Jane Schmidt | 2017-09-26 |